Tumour budding and its clinical implications in gastrointestinal cancers.

Zlobec, Inti; Berger, Martin D.; Lugli, Alessandro (2020). Tumour budding and its clinical implications in gastrointestinal cancers. British journal of cancer, 123(5), pp. 700-708. Nature Publishing Group 10.1038/s41416-020-0954-z

[img] Text
s41416-020-0954-z.pdf - Published Version
Restricted to registered users only until 30 June 2021.
Available under License Creative Commons: Attribution (CC-BY).
Note: This work is published under the standard license to publish agreement. After12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).

Download (910kB) | Request a copy

Tumour budding in colorectal cancer has become an important prognostic factor. Represented by single cells or small tumour cell clusters at the invasion front of the tumour mass, these tumour buds seem to reflect cells in a 'hybrid' state of epithelial-mesenchymal transition, and evidence indicates that the presence of these entities is associated with lymph node metastasis, local recurrence and distant metastatic disease. The International Tumour Budding Consensus Conference (ITBCC) has highlighted a scoring system for the reporting of tumour budding in colorectal cancer, as well as different clinical scenarios that could affect patient management. Other organs are not spared: tumour budding has been described in numerous gastrointestinal and non-gastrointestinal cancers. Here, we give an update on ITBCC validation studies in the context of colorectal cancer and the clinical implications of tumour budding throughout the upper gastrointestinal and pancreatico-biliary tract.

Item Type:

Journal Article (Review Article)


04 Faculty of Medicine > Service Sector > Institute of Pathology
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology

UniBE Contributor:

Zlobec, Inti; Berger, Martin Dave and Lugli, Alessandro


500 Science > 570 Life sciences; biology
600 Technology > 610 Medicine & health




Nature Publishing Group




Rebeka Gerber

Date Deposited:

26 Aug 2020 11:20

Last Modified:

08 Sep 2020 13:20

Publisher DOI:


PubMed ID:






Actions (login required)

Edit item Edit item
Provide Feedback